AGS sells Carshalton site to Q-Rad for £4m

By
Liz Hamson

Share this:

AGS Property Investments (2015) has sold a 2.47-acre freehold site in Carshalton to private healthcare company Q-Rad for £4m.

Q-Rad intends to use the three buildings at 1 and 3 Metcalfe Avenue, which provide circa 19,814 sq ft of space, to accommodate its operational needs. 

The site, which represents the final remaining parcel of the former Queen Mary’s Hospital estate, had been the subject of pre-application discussions for a 30-home residential scheme.

Navaratna-Rajah, from Q-Rad, said: “We are delighted to have completed the acquisition of the remaining three buildings at 1 and 3 Metcalfe Avenue, a site with a long and important healthcare history in Carshalton and Sutton as part of the former Queen Mary’s Hospital. We want to build on that heritage by creating an exciting future for healthcare at the site, while respecting its green surroundings and the special place it holds in the local community.  

“For us, this is about more than property development; it is about creating something positive, community-minded and giving something back. We would also like to thank Knight Frank and AGS Property Investments for their professionalism and support throughout the transaction.” 

Nick Alderman, head of Central London land at Knight Frank, which acted on behalf of AGS, added: “It was a pleasure to connect our client, AGS, with Q-Rad, and we’re delighted to have successfully facilitated this important transaction. From the outset, there was strong interest in the site, reflecting both its location and the range of uses it could accommodate. What made Q-Rad’s proposal particularly appealing was the opportunity to bring the property back into active healthcare use. Given its history as part of the wider Queen Mary’s Hospital estate, it’s encouraging to see the site continue to serve the local community in such a meaningful way.”

Get the latest news!

Don’t miss our top stories and need to know news every day in your inbox.

LATEST

NEWS

REGISTER TODAY

to get our daily newsletter, with all the latest news, views and analysis, delivered straight to your inbox – for FREE!